1
|
Edwards AG, Grandi E, Hake JE, Patel S, Li P, Miyamoto S, Omens JH, Heller Brown J, Bers DM, McCulloch AD. Nonequilibrium reactivation of Na+ current drives early afterdepolarizations in mouse ventricle. Circ Arrhythm Electrophysiol 2014; 7:1205-13. [PMID: 25236710 DOI: 10.1161/circep.113.001666] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
BACKGROUND Early afterdepolarizations (EADs) are triggers of cardiac arrhythmia driven by L-type Ca(2+) current (ICaL) reactivation or sarcoplasmic reticulum Ca(2+) release and Na(+)/Ca(2+) exchange. In large mammals the positive action potential plateau promotes ICaL reactivation, and the current paradigm holds that cardiac EAD dynamics are dominated by interaction between ICaL and the repolarizing K(+) currents. However, EADs are also frequent in the rapidly repolarizing mouse action potential, which should not readily permit ICaL reactivation. This suggests that murine EADs exhibit unique dynamics, which are key for interpreting arrhythmia mechanisms in this ubiquitous model organism. We investigated these dynamics in myocytes from arrhythmia-susceptible calcium calmodulin-dependent protein kinase II delta C (CaMKIIδC)-overexpressing mice (Tg), and via computational simulations. METHODS AND RESULTS In Tg myocytes, β-adrenergic challenge slowed late repolarization, potentiated sarcoplasmic reticulum Ca(2+) release, and initiated EADs below the ICaL activation range (-47 ± 0.7 mV). These EADs were abolished by caffeine and tetrodotoxin (but not ranolazine), suggesting that sarcoplasmic reticulum Ca(2+) release and Na(+) current (INa), but not late INa, are required for EAD initiation. Simulations suggest that potentiated sarcoplasmic reticulum Ca(2+) release and Na(+)/Ca(2+) exchange shape late action potential repolarization to favor nonequilibrium reactivation of INa and thereby drive the EAD upstroke. Action potential clamp experiments suggest that lidocaine eliminates virtually all inward current elicited by EADs, and that this effect occurs at concentrations (40-60 μmol/L) for which lidocaine remains specific for inactivated Na(+) channels. This strongly suggests that previously inactive channels are recruited during the EAD upstroke, and that nonequilibrium INa dynamics underlie murine EADs. CONCLUSIONS Nonequilibrium reactivation of INa drives murine EADs.
Collapse
Affiliation(s)
- Andrew G Edwards
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.).
| | - Eleonora Grandi
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Johan E Hake
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Sonia Patel
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Pan Li
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Shigeki Miyamoto
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Jeffrey H Omens
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Joan Heller Brown
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Donald M Bers
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| | - Andrew D McCulloch
- From the Department of Bioengineering (A.G.E., S.P., J.H.O., A.D.M.), Department of Pharmacology (S.M., J.H.B.), University of California, San Diego, La Jolla; Department of Pharmacology, University of California, Davis (E.G., D.M.B.); and Simula Research Laboratory, Center for Biomedical Computing, Lysaker, Oslo, Norway (J.E.H., P.L.)
| |
Collapse
|
4
|
Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998; 18:2-25. [PMID: 9428302 DOI: 10.1097/00004647-199801000-00002] [Citation(s) in RCA: 236] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
White matter of the brain and spinal cord is susceptible to anoxia and ischemia. Irreversible injury to this tissue can have serious consequences for the overall function of the CNS through disruption of signal transmission. Myelinated axons of the CNS are critically dependent on a continuous supply of energy largely generated through oxidative phosphorylation. Anoxia and ischemia cause rapid energy depletion, failure of the Na(+)-K(+)-ATPase, and accumulation of axoplasmic Na+ through noninactivating Na+ channels, with concentrations approaching 100 mmol/L after 60 minutes of anoxia. Coupled with severe K+ depletion that results in large membrane depolarization, high [Na+]i stimulates reverse Na(+)-Ca2+ exchange and axonal Ca2+ overload. A component of Ca2+ entry occurs directly through Na+ channels. The excessive accumulation of Ca2+ in turn activates various Ca(2+)-dependent enzymes, such as calpain, phospholipases, and protein kinase C, resulting in irreversible injury. The latter enzyme may be involved in "autoprotection," triggered by release of endogenous gamma-aminobutyric acid and adenosine, by modulation of certain elements responsible for deregulation of ion homeostasis. Glycolytic block, in contrast to anoxia alone, appears to preferentially mobilize internal Ca2+ stores; as control of internal Ca2+ pools is lost, excessive release from this compartment may itself contribute to axonal damage. Reoxygenation paradoxically accelerates injury in many axons, possibly as a result of severe mitochondrial Ca2+ overload leading to a secondary failure of respiration. Although glia are relatively resistant to anoxia, oligodendrocytes and the myelin sheath may be damaged by glutamate released by reverse Na(+)-glutamate transport. Use-dependent Na+ channel blockers, particularly charged compounds such as QX-314, are highly neuroprotective in vitro, but only agents that exist partially in a neutral form, such as mexiletine and tocainide, are effective after systemic administration, because charged species cannot penetrate the blood-brain barrier easily. These concepts may also apply to other white matter disorders, such as spinal cord injury or diffuse axonal injury in brain trauma. Moreover, whereas many events are unique to white matter injury, a number of steps are common to both gray and white matter anoxia and ischemia. Optimal protection of the CNS as a whole will therefore require combination therapy aimed at unique steps in gray and white matter regions, or intervention at common points in the injury cascades.
Collapse
Affiliation(s)
- P K Stys
- Ottawa Civic Hospital Loeb Medical Research Institute, University of Ottawa, Ontario, Canada
| |
Collapse
|
5
|
Seppet EK, Kolar F, Dixon IM, Hata T, Dhalla NS. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone. Mol Cell Biochem 1993; 129:145-59. [PMID: 8177237 DOI: 10.1007/bf00926363] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
In order to examine the regulatory role of thyroid hormone on sarcolemmal Ca(2+)-channels, Na(+)-Ca2+ exchange and Ca(2+)-pump as well as heart function, the effects of hypothyroidism and hyperthyroidism on rat heart performance and sarcolemmal Ca(2+)-handling were studied. Hyperthyroid rats showed higher values for heart rate (HR), maximal rates of ventricular pressure development +(dP/dt)max and pressure fall -(dP/dt)max, but shorter time to peak ventricular pressure (TPVP) and contraction time (CT) when compared with euthyroid rats. The left ventricular systolic pressure (LVSP) and left ventricular end-diastolic pressure (LVEDP), as well as aortic systolic and diastolic pressures (ASP and ADP, respectively) were not significantly altered. Hypothyroid rats exhibited decreased values of LVSP, HR, ASP, ADP, +(dP/dt)max and -(dP/dt)max but higher CT when compared with euthyroid rats; the values of LVEDP and TPVP were not changed. Studies with isolated-perfused hearts showed that while hypothyroidism did not modulate the inotropic response to extracellular Ca2+ and Ca2+ channel blocker verapamil, hyperthyroidism increased sensitivity to Ca2+ and decreased sensitivity to verapamil in comparison to euthyroid hearts. Studies of [3H]-nitrendipine binding with purified cardiac sarcolemmal membrane revealed decreased number of high affinity binding sites (Bmax) without any change in the dissociation constant for receptor-ligand complex (Kd) in the hyperthyroid group when compared with euthyroid sarcolemma; hypothyroidism had no effect on these parameters. The activities of sarcolemmal Ca(2+)-stimulated ATPase, ATP-dependent Ca2+ uptake and ouabain-sensitive Na(+)-K+ ATPase were decreased whereas the Mg(2+)-ATPase activity was increased in hypothyroid hearts. On the other hand, sarcolemmal membranes from hyperthyroid samples exhibited increased ouabain-sensitive Na(+)-K+ ATPase activity, whereas Ca(2+)-stimulated ATPase, ATP-dependent Ca2+ uptake, and Mg(2+)-ATPase activities were unchanged. The Vmax and Ka for Ca2+ of cardiac sarcolemmal Na(+)-Ca2+ exchange were not altered in both hyperthyroid and hypothyroid states. These results indicate that the status of sarcolemmal Ca(2+)-transport processes is regulated by thyroid hormones and the modification of Ca(2+)-fluxes across the sarcolemmal membrane may play a crucial role in the development of thyroid state-dependent contractile changes in the heart.
Collapse
Affiliation(s)
- E K Seppet
- Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada
| | | | | | | | | |
Collapse
|
6
|
Sarkadi B, Parker JC. Activation of ion transport pathways by changes in cell volume. BIOCHIMICA ET BIOPHYSICA ACTA 1991; 1071:407-27. [PMID: 1721542 DOI: 10.1016/0304-4157(91)90005-h] [Citation(s) in RCA: 231] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Swelling-activated K+ and Cl- channels, which mediate RVD, are found in most cell types. Prominent exceptions to this rule include red cells, which together with some types of epithelia, utilize electroneutral [K(+)-Cl-] cotransport for down-regulation of volume. Shrinkage-activated Na+/H+ exchange and [Na(+)-K(+)-2 Cl-] cotransport mediate RVI in many cell types, although the activation of these systems may require special conditions, such as previous RVD. Swelling-activated K+/H+ exchange and Ca2+/Na+ exchange seem to be restricted to certain species of red cells. Swelling-activated calcium channels, although not carrying sufficient ion flux to contribute to volume changes may play an important role in the activation of transport pathways. In this review of volume-activated ion transport pathways we have concentrated on regulatory phenomena. We have listed known secondary messenger pathways that modulate volume-activated transporters, although the evidence that volume signals are transduced via these systems is preliminary. We have focused on several mechanisms that might function as volume sensors. In our view, the most important candidates for this role are the structures which detect deformation or stretching of the membrane and the skeletal filaments attached to it, and the extraordinary effects that small changes in concentration of cytoplasmic macromolecules may exert on the activities of cytoplasmic and membrane enzymes (macromolecular crowding). It is noteworthy that volume-activated ion transporters are intercalated into the cellular signaling network as receptors, messengers and effectors. Stretch-activated ion channels may serve as receptors for cell volume itself. Cell swelling or shrinkage may serve a messenger function in the communication between opposing surfaces of epithelia, or in the regulation of metabolic pathways in the liver. Finally, these transporters may act as effector systems when they perform regulatory volume increase or decrease. This review discusses several examples in which relatively simple methods of examining volume regulation led to the discovery of transporters ultimately found to play key roles in the transmission of information within the cell. So, why volume? Because it's functionally important, it's relatively cheap (if you happened to have everything else, you only need some distilled water or concentrated salt solution), and since it involves many disciplines of experimental biology, it's fun to do.
Collapse
Affiliation(s)
- B Sarkadi
- National Institute of Haematology and Blood Transfusion, Budapest, Hungary
| | | |
Collapse
|